Polypharmacy Archives - Wiser Healthcare

Exploring Different Contexts of Statin Deprescribing: A Vignette-Based Experiment with Older Adults Across Four Countries – Kristie Rebecca Weir et al.

Lucia Marcello2024-04-07T16:33:55+10:00Ageing, Deprescribing, Polypharmacy, Primary Care, Publications, Risk|

Deprescribing is the process of a healthcare professional reducing or stopping an inappropriate medication. Statins, commonly prescribed to prevent cardiovascular events, pose uncertain benefits and potential harms for older adults, making deprescribing a preference-sensitive decision. Deprescribing studies typically ask general questions about deprescribing preferences; however, [...]

Cohort profile: Using primary care data to understand Opioid Prescribing, Policy Impacts and Clinical Outcomes (OPPICO) in Victoria, Australia – Suzanne Nielsen et al

Lucia Marcello2023-06-28T13:19:05+10:00Opioids, Pain, Polypharmacy, Prescribing, Publications|

The OPPICO cohort is a population-based cohort based on non-identifiable electronic health records routinely collected from 464 general practices in Victoria, Australia, created with the aim of understanding opioid prescribing, policy impacts and clinical outcomes. The aim of this paper is to provide a profile [...]

Anticholinergic burden measures, symptoms, and fall-associated risk in older adults with polypharmacy: Development and validation of a prognostic model – Truc Sophia Dinh et. al

Lucia Marcello2023-01-27T11:39:32+11:00Ageing, Health literacy, Polypharmacy, Prescribing, Publications, Risk|

Anticholinergic burden has been associated with adverse outcomes such as falls. To date, no gold standard measure has been identified to assess anticholinergic burden, and no conclusion has been drawn on which of the different measure algorithms best predicts falls in older patients from general [...]

Overuse of medications in low- and middle-income countries: a scoping review – Loai Albarqouni et. al

Lucia Marcello2023-01-25T15:20:38+11:00Low-value care, Overdiagnosis, Overtreatment, Overuse, Polypharmacy, Publications|

Growing evidence suggests overuse of medications is widespread within low- and middle-income countries, across multiple drug classes, with few data of solutions from randomized trials. Opportunities exist to build collaborations to rigorously develop and evaluate potential solutions to reduce overuse of medications.

NICE: Polypharmacy and shared decision-making: development of a conversation guide

Thomas Dakin2019-09-06T13:58:57+10:00News, Polypharmacy|

Researchers in Australia have developed and tested a conversation guide for pharmacists conducting medication reviews with older people. It addresses matters such as general health understanding, health priorities for medicines, the person’s goals and fears, views about what activities are important to them, and making [...]

Reducing Inappropriate Polypharmacy The Process of Deprescribing – Ian A Scott et. al.

Thomas Dakin2019-02-08T10:42:39+11:00Health literacy, Polypharmacy, Publications|

Inappropriate polypharmacy, especially in older people, imposes a substantial burden of adverse drug events, ill health, disability, hospitalization, and even death. The single most important predictor of inappropriate prescribing and risk of adverse drug events in older patients is the number of prescribed drugs. Deprescribing [...]

Polypharmacy

Exploring Different Contexts of Statin Deprescribing: A Vignette-Based Experiment with Older Adults Across Four Countries – Kristie Rebecca Weir et al.

Cohort profile: Using primary care data to understand Opioid Prescribing, Policy Impacts and Clinical Outcomes (OPPICO) in Victoria, Australia – Suzanne Nielsen et al

Anticholinergic burden measures, symptoms, and fall-associated risk in older adults with polypharmacy: Development and validation of a prognostic model – Truc Sophia Dinh et. al

Overuse of medications in low- and middle-income countries: a scoping review – Loai Albarqouni et. al

NICE: Polypharmacy and shared decision-making: development of a conversation guide

Reducing Inappropriate Polypharmacy The Process of Deprescribing – Ian A Scott et. al.

Staff Intranet